Evidence map›Paper›PMID 18543083›Full record

ArticleMolecular and cellular biochemistry2008

Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells.

Tatsuo Tani, Rie Ayuzawa, Tetsuo Takagi, Tsutomu Kanehira, Dharmendra Kumar Maurya, Masaaki Tamura

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Angiotensin ATFrontiers in immunology · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.American journal of physiology. Regulatory, integrative and comparative physiology · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tatsuo TaniDepartment of Biochemistry, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA.
Rie Ayuzawa
Tetsuo Takagi
Tsutomu Kanehira
Dharmendra Kumar Maurya
Masaaki Tamura
Kansas State University · USVanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
TARGETING NOTCH 3 IN LUNG CANCERP50CA090949 · NCI · VANDERBILT UNIVERSITY · PI MASSION, PIERRE P. · 2001 to 2011
$24.1M
Prevention of colon cancer by an AT2 receptor antagonistR03CA091428 · NCI · VANDERBILT UNIVERSITY · PI TAMURA, MASAAKI · 2001 to 2002
$151k
NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA 68485NCI NIH HHS P50 CA090949NCI NIH HHS P50 CA 90949NCI NIH HHS R03 CA 091428NCI NIH HHS R03 CA091428
6 · The paper itself

Abstract

We previously demonstrated that angiotensin II (Ang II) receptor signaling is involved in azoxymethane-induced mouse colon tumorigenesis. In order to clarify the role of Ang II in COX-2 expression in the intestinal epithelium, the receptor subtype-specific effect on COX-2 expression in a rat intestinal epithelial cell line (RIE-1) has been investigated. Ang II dose- and time-dependently increased the expression of COX-2, but not COX-1 mRNA and protein. This stimulation was completely blocked by the AT(1) receptor antagonist but not the AT(2) receptor antagonist. Ang II and lipopolysaccharide (LPS) additively induced COX-2 protein in RIE-1 cells, whereas the LPS-induced COX-2 expression was significantly attenuated by low concentrations of Ang II or the AT(2) agonistic peptide CGP-42112A only in AT(2) over-expressed cells. These data indicate that Ang II bi-directionally regulates COX-2 expression via both AT(1) and AT(2) receptors. Control of COX-2 expression through Ang II signaling may have significance in cytokine-induced COX-2 induction and colon tumorigenesis.

Indexed as

Angiotensin IIAngiotensin II Type 2 Receptor BlockersAnimalsCyclooxygenase 1Cyclooxygenase 2Drug SynergismEpithelial CellsGene Expression Regulation, EnzymologicIntestinesLipopolysaccharidesRatsReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Angiotensin IIAngiotensin II Type 2 Receptor BlockersCyclooxygenase 1Cyclooxygenase 2LipopolysaccharidesReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2

Identifiers

PMID18543083
PMCPMC2950175
OpenAlexW2062076920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.